Integrating Precision Medicine into Standard of Care for Children with Thyroid Cancer
Published on in CHOP News
Read this case study about integrating precision medicine into the standard of care for children with thyroid cancer.
Published on in CHOP News
Read this case study about integrating precision medicine into the standard of care for children with thyroid cancer.
Published on in CHOP News
A national leader in pediatric oncology research and treatment, Dr. Laetsch will also lead CHOP’s Developmental Therapeutics Program.
Published on in Cancer Connections
The history of our understanding and approach to cancer are at the center of CANCER: THE EMPEROR OF ALL MALADIES. The documentary will air in three parts on March 30, 31 and April 1 at 9 p.m. ET on PBS, with the final chapter featuring CHOP.
Published on in CHOP News
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.
Published on in Oncology Update
As new agents become more specific and target molecular characteristics of specific cancers, clinical trial enrollment may be restricted to children with relapsed cancers that harbor selected mutations.